Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study

This study examines subclinical lymphatic abnormalities in Tetralogy of Fallot patients, utilizing lymphatic magnetic resonance and near-infrared fluorescence imaging.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tetralogy of Fallot Cardiovascular Abnormalities Cardiovascular Diseases Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Heart Defects, Congenital Heart Diseases Lymphatic

Age range

6 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Rigshospitalet

København Ø, 2100, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Exclusion criteria

Treatment and study plan

Primary outcomes

Lymphatic abnormalities

Time frame: During scan

MRI assessed lymphatic abnormalities

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Oct 24, 2023
Registry last updated: Oct 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed